These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Advancing a vaccine to prevent human schistosomiasis. Merrifield M; Hotez PJ; Beaumier CM; Gillespie P; Strych U; Hayward T; Bottazzi ME Vaccine; 2016 Jun; 34(26):2988-2991. PubMed ID: 27036511 [TBL] [Abstract][Full Text] [Related]
6. Current status and future prospects for a vaccine against schistosomiasis. Lebens M; Sun JB; Czerkinsky C; Holmgren J Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948 [TBL] [Abstract][Full Text] [Related]
8. Schistosome vaccines: a critical appraisal. Wilson RA; Coulson PS Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():13-20. PubMed ID: 17308743 [TBL] [Abstract][Full Text] [Related]
9. Still hope for schistosomiasis vaccine. Ricciardi A; Ndao M Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659 [TBL] [Abstract][Full Text] [Related]
10. Progress on vaccines against parasites. Engers HD; Bergquist R; Modabber F Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004 [TBL] [Abstract][Full Text] [Related]
11. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Capron A; Riveau G; Capron M; Trottein F Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines. Alsallaq RA; Gurarie D; Ndeffo Mbah M; Galvani A; King C PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005544. PubMed ID: 28410369 [TBL] [Abstract][Full Text] [Related]
13. Schistosome membrane proteins as vaccines. Loukas A; Tran M; Pearson MS Int J Parasitol; 2007 Mar; 37(3-4):257-63. PubMed ID: 17222846 [TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis vaccines: where do we stand? Tebeje BM; Harvie M; You H; Loukas A; McManus DP Parasit Vectors; 2016 Sep; 9(1):528. PubMed ID: 27716365 [TBL] [Abstract][Full Text] [Related]
15. Human schistosomiasis in the post mass drug administration era. Mutapi F; Maizels R; Fenwick A; Woolhouse M Lancet Infect Dis; 2017 Feb; 17(2):e42-e48. PubMed ID: 27988094 [TBL] [Abstract][Full Text] [Related]
16. Vaccine development against schistosomiasis from concepts to clinical trials. Capron A; Capron M; Riveau G Br Med Bull; 2002; 62():139-48. PubMed ID: 12176856 [TBL] [Abstract][Full Text] [Related]
17. [Challenge of developing anti-parasite vaccines in the tropics]. Rogier C Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789 [TBL] [Abstract][Full Text] [Related]
18. Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis. Cryz SJ Experientia; 1991 Feb; 47(2):146-51. PubMed ID: 2001716 [TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths. You H; Liu C; Du X; McManus DP Molecules; 2017 Sep; 22(9):. PubMed ID: 28906438 [TBL] [Abstract][Full Text] [Related]
20. Schistosomiasis elimination: lessons from the past guide the future. Gray DJ; McManus DP; Li Y; Williams GM; Bergquist R; Ross AG Lancet Infect Dis; 2010 Oct; 10(10):733-6. PubMed ID: 20705513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]